These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6987783)

  • 1. A comparison of skin and heart graft rejection patterns in H-2 mutant mice.
    Davis WC; McKenzie IF; Melvold RW
    Transplantation; 1980 Mar; 29(3):189-92. PubMed ID: 6987783
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential immunogenic expression of an H-2-linked histocompatibility antigen on different tissues. Differences in survival between heart, thyroid, and skin allografts.
    Isakov N; Yankelevich B; Segal S; Feldman M
    Transplantation; 1979 Jul; 28(1):31-5. PubMed ID: 377590
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of CD30 in skin and heart allograft rejection in the mouse.
    Beckmann J; Kurts C; Klebba I; Bayer B; Klempnauer J; Hoffmann MW
    Transplant Proc; 2001; 33(1-2):140-1. PubMed ID: 11266747
    [No Abstract]   [Full Text] [Related]  

  • 4. Haptens can serve as surrogate transplantation antigens in a manner that demonstrates H-2 restriction of graft rejection.
    Streilein JW; Bergstresser PR
    J Exp Med; 1983 Apr; 157(4):1354-9. PubMed ID: 6339670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active enhancement of donor-strain skin in mice bearing H-2D-incompatible heart allografts.
    Corry RJ; Kelley SE
    Transplant Proc; 1977 Mar; 9(1):945-9. PubMed ID: 325825
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of an H-2Kd mutant strain: C.B6-H-2dm4.
    Morgan G; Dellos H; McKenzie IF; Melvold RW
    Immunogenetics; 1981 Mar; 12(5-6):555-60. PubMed ID: 6452410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced tolerance to allografts in mice. III. Prolongation of skin graft survival by tolerance induction in congenic mice disparate in the major H-2 antigens.
    Shin T; Himeno K; Mayumi H; Nomoto K
    Transplantation; 1985 Mar; 39(3):333-5. PubMed ID: 3883602
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic control of allograft tolerance: importance of H-2 subregions.
    Click RE; Cahill G; Condie RM; Azar MM; Najarian JS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):582-5. PubMed ID: 7022894
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell-cell interaction in graft-rejection responses: breakdown of tolerance to allo-class I H-2 antigens by helper T cells against other histocompatibility antigens simultaneously expressed on a graft.
    Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
    Transplant Proc; 1991 Feb; 23(1 Pt 1):96-8. PubMed ID: 1825007
    [No Abstract]   [Full Text] [Related]  

  • 10. Fine specificity of class I MHC recognition in islet allografts.
    Ferguson D; Kohli N; Munn SR
    Transplant Proc; 1995 Dec; 27(6):3222. PubMed ID: 8539924
    [No Abstract]   [Full Text] [Related]  

  • 11. Graft rejection in donor-recipient pairs with differing of H-2 loci.
    Chen S; Ascher NL; Bach FH; Simmons RL
    Surg Forum; 1979; 30():274-6. PubMed ID: 395682
    [No Abstract]   [Full Text] [Related]  

  • 12. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
    Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM
    Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid graft rejection between C57BL/6 and H-2Kb mutant mice. Differences in the immunogenic expression of the mutated molecule on thyroids of six different mutants.
    Isakov N; Bach FH
    Transplantation; 1983 Nov; 36(5):571-7. PubMed ID: 6356521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing alloantibody effective during sensitization but not effector phase of skin graft rejection.
    Sugarbaker PH; Chang AE
    Transplantation; 1979 Jul; 28(1):60-5. PubMed ID: 377597
    [No Abstract]   [Full Text] [Related]  

  • 15. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spontaneous mutation of the H-2b-haplotype in C57BL/10SnY mice].
    Blandova ZK; Rat'kin AE
    Genetika; 1987 Jul; 23(7):1334-6. PubMed ID: 3308634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effector mechanism of H-Y and non-H-2 incompatible skin graft rejection in mice.
    Ichikawa T; Kawai M; Uenaka A; Yamamoto H; Gotoh M; Mondon M; Mori T; Shiku H; Nakayama E
    Transplant Proc; 1989 Feb; 21(1 Pt 1):156-7. PubMed ID: 2650099
    [No Abstract]   [Full Text] [Related]  

  • 18. Is recipient priming with graft foreign antigen a prerequisite for the blood transfusion effect?
    Corry RJ; Shelby J; David C; Heffner C; Billingsley A; Kelley SE
    Transplant Proc; 1982 Jun; 14(2):391-3. PubMed ID: 6180531
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic control of transplant rejection.
    Butcher GW; Howard JC
    Transplantation; 1982 Oct; 34(4):161-6. PubMed ID: 6815843
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.